Financial conflicts of interest in clinical research

Jelena Savović^{1

2}, Elie A Akl^{3

4}, Asbjørn Hróbjartsson^{5

6

7}

Affiliations

¹ Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK. J.Savovic@bristol.ac.uk.
² National Institute of Health Research Collaboration for Leadership in Applied Health Research and Care West (CLAHRC West), University Hospitals Bristol NHS Foundation Trust, Bristol, UK. J.Savovic@bristol.ac.uk.
³ Department of Internal Medicine, American University of Beirut, Beirut, Lebanon.
⁴ Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, ON, Canada.
⁵ Centre for Evidence-Based Medicine Odense (CEBMO), Odense University Hospital, Odense, Denmark.
⁶ Odense Patient Explorative Data Network (OPEN), Odense University Hospital, Odense, Denmark.
⁷ Department of Clinical Research, University of Southern Denmark, Odense, Denmark.

Editorial

Jelena Savović et al. Intensive Care Med. 2018 Oct.

. 2018 Oct;44(10):1767-1769.

doi: 10.1007/s00134-018-5333-3. Epub 2018 Aug 20.

Jelena Savović^{1

2}, Elie A Akl^{3

4}, Asbjørn Hróbjartsson^{5

6

7}

¹ Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK. J.Savovic@bristol.ac.uk.
² National Institute of Health Research Collaboration for Leadership in Applied Health Research and Care West (CLAHRC West), University Hospitals Bristol NHS Foundation Trust, Bristol, UK. J.Savovic@bristol.ac.uk.
³ Department of Internal Medicine, American University of Beirut, Beirut, Lebanon.
⁴ Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, ON, Canada.
⁵ Centre for Evidence-Based Medicine Odense (CEBMO), Odense University Hospital, Odense, Denmark.
⁶ Odense Patient Explorative Data Network (OPEN), Odense University Hospital, Odense, Denmark.
⁷ Department of Clinical Research, University of Southern Denmark, Odense, Denmark.

No abstract available

References

1. Riechelmann RP, Wang L, O’Carroll A, Krzyzanowska MK (2007) Disclosure of conflicts of interest by authors of clinical trials and editorials in oncology. J Clin Oncol 25(29):4642–4647 - DOI
1. Rothenstein JM, Tomlinson G, Tannock IF, Detsky AS (2011) Company stock prices before and after public announcements related to oncology drugs. J Natl Cancer Inst 103(20):1507–1512 - DOI
1. Le Noury J, Nardo JM, Healy D et al (2015) Restoring Study 329: efficacy and harms of paroxetine and imipramine in treatment of major depression in adolescence. BMJ 351(7):h4320 - DOI
1. Wojcik J (2012) Pharma giant threatens Danish scientist. Science nordic. http://sciencenordic.com/pharma-giant-threatens-danish-scientist . Accessed 15 June 2018
1. Lo B, Field MJ (eds) (2009) Conflict of interest in medical research, education, and practice. Institute of Medicine (US) Committee on conflict of interest in medical research, education, and practice. National Academies Press (US), Washington (DC)